Cargando…
Positron emission tomography in uro-oncology
Positron emission tomography (PET) in uro-oncology has been one of the slowest areas to develop. There are problems because of the excretion of tracer through the renal tract. Its use in prostate cancer has generally being disappointing, with PET being unable to differentiate malignancy from benign...
Autor principal: | Hain, S F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-MED
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665217/ https://www.ncbi.nlm.nih.gov/pubmed/16154810 http://dx.doi.org/10.1102/1470-7330.2005.0001 |
Ejemplares similares
-
The applications of positron emission tomography to oncology.
por: Ott, R. J.
Publicado: (1991) -
Positron Emission Tomography (PET) in Oncology
por: Gallamini, Andrea, et al.
Publicado: (2014) -
Robotics in uro-oncologic surgery
por: De Lorenzis, Elisa, et al.
Publicado: (2013) -
Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology †
por: Rangger, Christine, et al.
Publicado: (2020) -
Positron Emission Tomography-Based Response to Target and Immunotherapies in Oncology
por: Donegani, Maria Isabella, et al.
Publicado: (2020)